Page last updated: 2024-09-05

vx-745 and Stroke

vx-745 has been researched along with Stroke in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Alam, JJ; Germann, U; Krakovsky, M; Levy, A	1

Other Studies

1 other study(ies) available for vx-745 and Stroke

Article	Year
Continuous administration of a p38α inhibitor during the subacute phase after transient ischemia-induced stroke in the rat promotes dose-dependent functional recovery accompanied by increase in brain BDNF protein level. PloS one, 2020, Volume: 15, Issue:12 Topics: Animals; Brain; Brain Ischemia; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Ischemia; Male; Mitogen-Activated Protein Kinase 14; p38 Mitogen-Activated Protein Kinases; Pyridazines; Pyrimidines; Rats; Rats, Sprague-Dawley; Recovery of Function; Stroke	2020

Article

Year

Continuous administration of a p38α inhibitor during the subacute phase after transient ischemia-induced stroke in the rat promotes dose-dependent functional recovery accompanied by increase in brain BDNF protein level.

PloS one, 2020, Volume: 15, Issue:12

Topics: Animals; Brain; Brain Ischemia; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Ischemia; Male; Mitogen-Activated Protein Kinase 14; p38 Mitogen-Activated Protein Kinases; Pyridazines; Pyrimidines; Rats; Rats, Sprague-Dawley; Recovery of Function; Stroke

2020